Eli Lilly & Co. (LLY) Misses Q3 EPS by 27c; guides below consensus
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,208.12 +7.13%
Revenue Growth %: +31.7%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +31.7%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.18, $0.27 worse than the analyst estimate of $1.45. Revenue for the quarter came in at $11.44 billion versus the consensus estimate of $12.09 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2024 EPS of $13.02-$13.52, versus the consensus of $13.50. Eli Lilly & Co. sees FY2024 revenue of $45.4-46 billion, versus the consensus of $46.25 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- FDA approves AbbVie's Skyrizi for children with psoriatic disease
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
